GlucaGen® (glucagon [rDNA origin]) HypoKit®
What is GlucaGen® HypoKit®?
GlucaGen® (glucagon [rDNA origin]) HypoKit® is Novo Nordisk’s glucagon emergency kit for the
treatment of severe low blood sugar. It contains an injection of glucagon, a hormone that raises your blood sugar level.
Glucagon works by triggering the liver to release stored sugar, raising blood sugar
levels. It is injected under the skin, similar to how insulin is injected.
Your doctor might prescribe GlucaGen® HypoKit® for one of the following
- Works fast—GlucaGen® HypoKit® begins to raise
blood sugar levels within about 10 minutes after an injection.
- Goes with you—No refrigeration needed, so you can keep
GlucaGen® HypoKit® handy at all times.
- GlucaGen® HypoKit® contains 1 mg (1 unit) of glucagon
and a disposable syringe with sterile water.
- Protective, bright orange case—GlucaGen® HypoKit®
is easy to carry and easy to spot in an emergency.
- Easy-to-follow picture instructions—The instructions
on the protective case show family and friends how to give an injection if you suffer
a severe hypoglycemic event.
Talk to your doctor or your diabetes care team about the ways in which GlucaGen®
HypoKit® can treat you in the event of a severe hypoglycemic event.
Remember, if you are having a severe hypoglycemic emergency, you will not be able
to treat yourself. You will need help from others around you. Make sure your family,
friends, and coworkers know where to find and how to use the GlucaGen® HypoKit®.
Indications and Usage for GlucaGen® HypoKit® (glucagon [rDNA origin] for injection):
GlucaGen® is a prescription medicine used to treat very low blood sugar (severe hypoglycemia)
that can happen in people who have diabetes and use insulin. Symptoms of severe hypoglycemia
include confusion, loss of consciousness, and seizures. You should only give GlucaGen® injection
if (1) the person is unconscious or (2) the person is having a seizure or (3) the person
is confused and unable to eat sugar or a sugar-sweetened product. Less severe cases
of hypoglycemia should be treated right away by eating sugar or a sugar sweetened
product such as a regular soft drink or fruit juice. GlucaGen® does not work if
it is taken by mouth.
Important Safety Information for GlucaGen® HypoKit®:
Do not use GlucaGen® if you are allergic to glucagon or lactose, have a tumor of
the adrenal gland called a pheochromocytoma, or have a tumor of the pancreas called
Hypoglycemia may happen again after receiving GlucaGen® treatment. You must be given
a fast-acting source of sugar followed by a long-acting source of sugar by mouth
as soon as you are awake and able to swallow.
Tell your doctor about all medicines you take and all of your medical conditions,
including if you are pregnant or breastfeeding. GlucaGen® may affect the way other
medicines work, and other medicines may affect how GlucaGen® works.
GlucaGen® may cause serious side effects including allergic reactions. Symptoms
of a severe allergic reaction may include rash or itching, raised red patches on
your skin (hives), swelling of the face, lips, tongue or throat, problems breathing
or swallowing, very high or very low blood pressure, or fast or slow heart beat.
The most common side effects of GlucaGen® include nausea and vomiting.
Please click here for the GlucaGen®
Prescribing Information and GlucaGen® HypoKit® Patient Information.
Talk to your doctor about the importance of diet and exercise in your treatment
You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch, or call
If you need assistance with prescription drug costs, help may be available. Visit
pparx.org or call 1-888-4PPA-NOW.
FlexPen®, Levemir®, Novolin®, and NovoLog®NovoLog®, and Victoza® are registered trademarks
of Novo Nordisk A/S.
Bydureon™ is a trademark and Byetta® and Symlin® are
registered trademarks of Amylin Pharmaceuticals, Inc. Humalog® and
Humulin® are registered trademarks and KwikPen™ is a trademark of Eli
Lilly and Company. Apidra®, Lantus®, and SoloSTAR® are registered trademarks
of sanofi-aventis U.S. LLC.
FlexPen®, Levemir®, Novolin®, y NovoLog®NovoLog®, y Victoza® son marcas registradas
de Novo Nordisk A/S.
Bydureon™ es una marca, y Byetta® y Symlin® son marcas registradas
de Amylin Pharmaceutical, Inc. Humalog® y Humulin® son marcas registradas, y KwikPen™
es una marca de Eli Lilly and company. Apidra®, Lantus® y SoloSTAR® son marcas registradas
de sanofi-aventis U.S. LLC.
GlucaGen® and HypoKit® are registered trademarks of Novo Nordisk A/S.